PT-141 10mg Dosage Protocol

1. Preparation and Measurement

PT-141 10mg With 2mL of Diluent

Add 2mL of bacteriostatic water to the vial. The resulting concentration is 5mg/mL. On a U-100 syringe, each unit contains 50mcg.

Preparation

1. Draw 2mL of bacteriostatic water using sterile equipment.
2. Let the liquid run slowly down the inside wall of the vial.
3. Gently swirl until dissolved. Do not shake.
4. Label with the preparation date and refrigerate.

Check the calculation with the peptide calculator.

2. Commonly Documented Schedule

Route commonly described: subcutaneous in the approved comparator formulation. Frequency: no more than once in 24 hours in the comparator label.

Vial estimate: One 10mg vial contains approximately 5 documented-size administrations at 1.75mg.

Practical Notes

• The table applies only to this vial prepared with exactly 2mL.
• Record the amount, date, and preparation used.

3. Supplies Needed

• PT-141 10mg vial.
• 2mL of bacteriostatic water per vial.
• Sterile U-100 syringes.
• Alcohol swabs.
• Sharps container.

4. Storage and Handling

• Keep unopened vials cool, dry, dark, and protected from moisture.
• After preparation, refrigerate at 2-8 degrees C.
• Protect from light and avoid repeated freeze-thaw cycles.
• Do not use material with particles, discoloration, or a damaged seal.

5. Research Context

Bremelanotide is the active molecule in an approved prescription product with formulation-specific instructions, contraindications, and limits. That approval does not transfer to a laboratory vial.

The table reproduces the approved product's amount only as a documented comparator. This research material is not the approved drug product and is not interchangeable with it.

Primary Research and Regulatory References

1. Bremelanotide phase 3 clinical trials
2. Bremelanotide dose-finding study
3. FDA Vyleesi prescribing information